D-0139-2020 Class II Terminated

Recalled by Mylan Laboratories Limited (Sterile Products Division) — Bangalore, N/A

Recall Details

Product Type
Drugs
Report Date
October 16, 2019
Initiation Date
October 7, 2019
Termination Date
March 9, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19,165 vials

Product Description

Rifampin for Injection, USP, 600 mg/vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103; NDC 67457-445-60.

Reason for Recall

Failed Impurities/Degradation Specifications: discoloration due to elevated unknown impurity results which could decrease the effectiveness of the product.

Distribution Pattern

Nationwide in the USA

Code Information

Lot: 7008334, Exp April 2020; 7008417, Exp Oct 2020